DOW GEOFFREY S 4

What Happened
Geoffrey S. Dow, President & CEO and a director of 60 Degrees Pharmaceuticals (SXTP), made an open-market purchase of 7,350 shares on 2026-06-12 at $1.38 per share, for a total of $10,131. This was a straight purchase (code P) reported on a Form 4 filed 2026-06-15.

Key Details

• Transaction date: 2026-06-12 (open-market purchase)
• Price per share: $1.38; Shares acquired: 7,350; Total cost: $10,131
• Form 4 filed: 2026-06-15 (Accession no. 0001213900-26-068853) — appears to be timely (filed within the SEC 2-business-day window)
• Shares owned after transaction: not specified in the summary provided; see the full Form 4 for total holdings
• Transaction code: P (purchase). No footnotes, 10b5-1 plan, tax withholding, or other special conditions reported in the provided data

Context
An insider purchase by a CEO can be interpreted as a positive signal, but this is a relatively small transaction (~$10k) and alone does not indicate a major change in insider conviction. Retail investors should review the full Form 4 for total insider holdings and any footnotes, and consider this activity alongside company fundamentals and broader insider trading patterns.